Original Articles

Expression of p53 as a Prognostic Marker in low and high-grade Urothelial Carcinoma: A Cross-Sectional Analysis

  1. Senior Lecturer Pathology, CMH Medical College, Kharian
  2. Associate Pathology, Federal Govt Plyclinic PGMI, Islamabad
  3. Registrar Hisopathology dept, FUMC, Islamabad
  4. Assistant Professor, CMH Medical College, Kharian
  5. Assistant Professor Pathology, CMH Medical College, Kharian
  6. Associate Professor Pathology, CMH Medical College, Kharian
https://doi.org/10.48036/apims.v20i4.743

Abstract

Objective: To assess the expression of p53 and its correlation with histologic grade and tumor invasiveness in urothelial carcinoma.

Methodology: This cross-sectional study was conducted at the Department of Pathology, Pakistan Institute of Medical Sciences (PIMS), Islamabad, over duration of 24 months August 2018 to August 2020. A total of 96 cases of histologically confirmed urothelial carcinoma were analyzed using immunohistochemistry for p53 expression. p53 positivity was evaluated at 10% and 40% nuclear cut-offs, and further classified into wild-type and aberrant phenotypes. Associations with tumor grade, lamina propria invasion, and muscularis propria invasion were assessed using chi-square tests.

Results: High-grade tumors showed significantly higher p53 expression at both 10% (84.6%) and 40% (63.5%) cut-offs compared to low-grade tumors (45.5% and 22.7%, respectively) (p < 0.001). Aberrant phenotypes were more frequent in high-grade tumors (69.2%) versus low-grade (25%) (p < 0.001). p53 positivity was also significantly associated with lamina propria and muscularis propria invasion (p < 0.001).

Conclusion: p53 immunoexpression correlates strongly with tumor grade and invasion, highlighting its value as a prognostic marker in urothelial carcinoma.

Metrics

372Abstract views
511Downloads

Full Text

License

Copyright (c) 2024 AZMAT ALI

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue